Cargando…
C‐reactive protein: An independent predictor for dedifferentiated chondrosarcoma
Dedifferentiated chondrosarcoma is a rare primary bone malignancy with a very poor prognosis. The aim of the study was to identify pretreatment serum markers as prognostic factors for the overall survival (OS) of patients with dedifferentiated chondrosarcoma. We retrospectively reviewed 33 patients...
Autores principales: | Nemecek, Elena, Funovics, Philipp Theodor, Hobusch, Gerhard Martin, Lang, Susanna, Willegger, Madeleine, Sevelda, Florian, Brodowicz, Thomas, Stihsen, Christoph, Windhager, Reinhard, Panotopoulos, Joannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220779/ https://www.ncbi.nlm.nih.gov/pubmed/29701260 http://dx.doi.org/10.1002/jor.24030 |
Ejemplares similares
-
Oncological and surgical outcome after treatment of pelvic sarcomas
por: Puchner, Stephan E., et al.
Publicado: (2017) -
Is Total Femur Replacement a Reliable Treatment Option for Patients With Metastatic Carcinoma of the Femur?
por: Sevelda, Florian, et al.
Publicado: (2018) -
Diagnostic accuracy of ultrasound-guided core needle biopsy versus incisional biopsy in soft tissue sarcoma: an institutional experience
por: Cernakova, Miroslava, et al.
Publicado: (2021) -
C-reactive protein as a prognostic factor in patients with chordoma of lumbar spine and sacrum—a single center pilot study
por: Hobusch, Gerhard Martin, et al.
Publicado: (2016) -
High fibrinogen levels are associated with poor survival in patients with liposarcoma
por: Peschek, L. S., et al.
Publicado: (2023)